MANILA, Philippines – Some 1,500 Filipinos in the United Arab Emirates (UAE) have participated in the third trial of the Chinese company Sinpharm’s COVID-19 vaccine, said Chinese Ambassador to the Philippines Huang Xilian.
Approximately 1,500 Filipinos among more than 30,000 volunteers have participated in the phase III clinical trial of the Sinopharm COVID-19 candidate vaccine in the United Arab Emirates since June 23 and the aforementioned trial is the first phase of the clinical trial III of the world of the COVID-19 vaccine. “An embassy said Wednesday, mentioning Huang.
“Relevant tests of the Sinopharm vaccine against the primary strains of the COVID-19 virus, added to that of Beijing Xinfadi, as well as other regions of Russia, the United Kingdom, the United States, Austria, etc. , have shown promising effects in terms of protection and efficiency. ”Confident the envoy.
Huang also expressed optimism that the vaccine will likely be on the market until the end of December.
Along with Sinopharm vaccines, the Philippines are also the ones that are manufactured through Russia, Taiwan, Modern American biotech corporate, etc.
Previously, China had pledged to prioritize the Philippines once it develops a coronavirus vaccine.
The Inquirer Foundation supports our leaders in healthcare and accepts donations of money to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or to donate through PayMaya using this link.
We use cookies so that you get the most productive experience on our website. By continuing, you agree to our use of cookies. For more information, click on this link.